Citigroup’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $46.1K | Sell |
|
|||||
|
2025
Q2 | $459K | Sell |
|
|||||
|
2025
Q1 | $731K | Buy |
|
|||||
|
2024
Q4 | $862K | Buy |
|
|||||
|
2024
Q3 | $1.36M | Buy |
|
|||||
|
2024
Q2 | $575K | Sell |
|
|||||
|
2024
Q1 | $7.78M | Sell |
|
|||||
|
2023
Q4 | $6.73M | Buy |
|
|||||
|
2023
Q3 | $3.13M | Sell |
|
|||||
|
2023
Q2 | $6.14M | Sell |
|
|||||
|
2023
Q1 | $13.9M | Sell |
|
|||||
|
2022
Q4 | $19.8M | Sell |
|
|||||
|
2022
Q3 | $17.9M | Buy |
|
|||||
|
2022
Q2 | $12.8M | Buy |
|
|||||
|
2022
Q1 | $428K | Sell |
|
|||||
|
2021
Q4 | $1.88M | Buy |
|
|||||
|
2021
Q3 | $736K | Sell |
|
|||||
|
2021
Q2 | $1.76M | Sell |
|
|||||
|
2021
Q1 | $2.63M | Buy |
|
|||||
|
2020
Q4 | $233K | Buy |
|
|||||
|
2020
Q3 | $13K | Sell |
|
|||||
|
2020
Q2 | $35K | Buy |
|